YMAB   $14.325  5.25% Market Open

Y-mAbs Therapeutics Inc
Total Cash 77.81M
totalCashPerShare 1.746
EBITDA -27.00M
Total Debt 1.27M
quickRatio 2.3
currentRatio 2.916
Total Revenue 86.55M
debtToEquity 1.336
Revenue/Share 1.978
ROA -0.12501
ROE -0.24611
grossProfits
freeCashflow -5.68M
operatingCashflow -12.55M
earningsGrowth
revenueGrowth 0.099
grossMargins 0.88625
ebitdaMargins -0.31202
operatingMargins -0.42938
profitMargins -0.28439
enterpriseValue 535.86M
forwardPE -26.009806
floatShares 27.00M
sharesOutstanding 44.57M
sharesShort 4.19M
sharesShortPriorMonth 4.66M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.69%
Short Ratio help_outline 14.07%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 2.139
Price To Book help_outline 6.20
earningsQuarterlyGrowth
netIncomeToCommon -24.61M
trailingEps -0.56%
forwardEps -0.51%
enterpriseToEbitda -19.84
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.15 3Q 2024
institutionsCount 152
lastUpdated Sept. 16, 2024, 6:43 p.m.